{
    "@graph": [
        {
            "@id": "gnd:4596131-1",
            "sameAs": "High throughput screening"
        },
        {
            "@id": "https://www.tib.eu/de/suchen/id/TIBKAT%3A1657831736",
            "@type": "bibo:Book",
            "P1053": "1 Online-Ressource (xx, 396 Seiten)",
            "http://purl.org/dc/elements/1.1/contributor": [
                "Bittker, Joshua A.",
                "Ross, Nathan T."
            ],
            "description": [
                "Campusweiter Zugriff (Universit\u00e4t Hannover).- Vervielf\u00e4ltigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots.",
                "Illustrationen, Diagramme"
            ],
            "identifier": [
                "(isbn13)9781782629795",
                "(ppn)1657831736",
                "(doi)10.1039/9781782626770",
                "(firstid)BSZ:486931234",
                "(isbn13)9781782626770"
            ],
            "publisher": "Royal Society of Chemistry",
            "subject": [
                "(classificationName=ddc)615.1/9",
                "(classificationName=loc)RS419.5",
                "(classificationName=linsearch:mapping)meda",
                "High throughput screening (Drug development) ; fast ; (OCoLC)fst00956496",
                "High throughput screening (Drug development)",
                "(classificationName=bk, id=181571781)44.41 - Pharmazeutische Biologie",
                "Electronic books",
                "(classificationName=linsearch:mapping)hor",
                "(classificationName=linsearch:mapping)bio"
            ],
            "title": "High throughput screening methods : evolution and refinement",
            "abstract": [
                "This book serves as a practical reference for the current state of the art in high throughput screening, which remains a key part of early stage drug and tool compound discovery",
                "4.7.2 Isothermal Titration Calorimetry4.8 X-Ray Crystallography; 4.9 Newer Methods on the Horizon; 4.10 Summary and Recommendations; Acknowledgments; References; Chapter 5 Genetic Perturbation Methods, from the 'Awesome Power' of Yeast Genetics to the CRISPR Revolution; 5.1 Introduction; 5.2 Genetic Methodologies; 5.2.1 Random Mutagenesis; 5.2.2 Targeted Genome-wide Deletions (Homozygous/Heterozygous); 5.2.3 Random Genome-wide Deletions (Homozygous/Heterozygous); 5.2.4 RNA Interference; 5.2.5 CRISPR; 5.2.6 Overexpression; 5.2.7 Synthetic Biology; 5.3 Concluding Remarks; Acknowledgments",
                "Chapter 3 Combination Screening3.1 Introduction; 3.2 Measures of Synergy; 3.2.1 Bliss Independence Model of Synergy; 3.2.2 Loewe Additivity; 3.2.3 Other Measures; 3.2.4 Reconciling Measures of Synergy; 3.3 Design of Combination Experiments; 3.4 Statistical Inference of Combination Effects; 3.4.1 The Error Distribution; 3.4.2 Bootstrap Intervals; 3.4.3 Intervals for Bliss Independence; 3.4.4 Intervals for Loewe Additivity Interaction Index; 3.5 Null Hypothesis Significance Testing; 3.5.1 Significance Testing of Bliss; 3.5.2 Significance Test of Loewe Additivity; 3.6 Concluding Remarks",
                "Cover; Contents; Foreword: Transforming Medicine by Innovating the Science of Therapeutics; Preface; Chapter 1 HTS Methods: Assay Design and Optimisation; 1.1 Introduction; 1.2 HTS at AstraZeneca; 1.2.1 Criteria and Acceptance; 1.2.2 Robustness/Reliability; 1.2.3 Analysing Data to Define Robustness/Reliability; 1.2.4 As Simple to Run as Possible; 1.2.5 Assay Validation; 1.3 Summary; References; Chapter 2 Considerations Related to Small-molecule Screening Collections; 2.1 Introduction; 2.2 General Considerations Related to HTS Compound Collections; 2.2.1 Determination of Screening Objectives",
                "2.2.2 Size of HTS Compound Collections2.2.3 Chemical Diversity in Compound Collections; 2.2.4 Quality of Compounds in Screening Collections; 2.3 Sources of Compounds in Screening Collections; 2.3.1 Natural Products in Screening Collections; 2.3.2 Synthetic Drug-like Compounds; 2.3.3 Diverse Collections; 2.4 Performance of Compounds in Screening Collections; 2.4.1 Background; 2.4.2 Performance of Compounds from Different Sources; 2.4.3 Performance Diversity of Compound Collections; 2.4.4 Pan Assay Interference Compounds; 2.4.5 Dark Chemical Matter; 2.5 Conclusions and Discussion; References"
            ],
            "contributor": "Technische Informationsbibliothek (TIB)",
            "isPartOf": "(collectioncode)ZDB-1-RSEK",
            "issued": "2017",
            "language": "http://id.loc.gov/vocabulary/iso639-1/en",
            "license": "commercial licence",
            "medium": "rda:termList/RDACarrierType/1018",
            "dcterms:subject": {
                "@id": "gnd:4596131-1"
            },
            "volume": "no. 1",
            "isLike": "doi:10.1039/9781782626770",
            "P30128": [
                "RSC e-book collection",
                "Chemical biology series"
            ],
            "P60163": "Cambridge"
        }
    ],
    "@id": "urn:x-arq:DefaultGraphNode",
    "@context": {
        "publisher": "http://purl.org/dc/elements/1.1/publisher",
        "contributor": "http://purl.org/dc/terms/contributor",
        "subject": "http://purl.org/dc/elements/1.1/subject",
        "license": "http://purl.org/dc/terms/license",
        "volume": "http://purl.org/ontology/bibo/volume",
        "identifier": "http://purl.org/dc/elements/1.1/identifier",
        "abstract": "http://purl.org/dc/terms/abstract",
        "P30128": "http://www.rdaregistry.info/Elements/m/#P30128",
        "isPartOf": "http://purl.org/dc/terms/isPartOf",
        "isLike": {
            "@id": "http://umbel.org/umbel#isLike",
            "@type": "@id"
        },
        "description": "http://purl.org/dc/elements/1.1/description",
        "language": {
            "@id": "http://purl.org/dc/terms/language",
            "@type": "@id"
        },
        "title": "http://purl.org/dc/elements/1.1/title",
        "medium": {
            "@id": "http://purl.org/dc/terms/medium",
            "@type": "@id"
        },
        "P1053": "http://iflastandards.info/ns/isbd/elements/P1053",
        "issued": "http://purl.org/dc/terms/issued",
        "P60163": "http://www.rdaregistry.info/Elements/u/#P60163",
        "sameAs": "http://www.w3.org/2002/07/owl#sameAs",
        "umbel": "http://umbel.org/umbel#",
        "rdau": "http://www.rdaregistry.info/Elements/u/#",
        "owl": "http://www.w3.org/2002/07/owl#",
        "dcterms": "http://purl.org/dc/terms/",
        "bibo": "http://purl.org/ontology/bibo/",
        "rdam": "http://www.rdaregistry.info/Elements/m/#",
        "gnd": "http://d-nb.info/gnd/",
        "isbd": "http://iflastandards.info/ns/isbd/elements/",
        "rda": "http://rdvocab.info/",
        "doi": "https://doi.org/"
    }
}